Developing innovative treatment methods and creating new value
Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage.
We will do what it takes to offer patients new innovative treatment choices and stand true to the Otsuka corporate philosophy; “Otsuka-people creating new products for better health worldwide”.
Otsuka Medical Devices group video
| Company Name | Otsuka Medical Devices Co., Ltd. |
|---|---|
| Established | February 15th, 2011 |
| Capital | 7.55 billion yen |
| Head Office | 2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan |
| Tokyo Headquarters | Shinagawa Grand Central Tower 13F 2-16-4, Konan, Minato-ku, Tokyo 108-0075, Japan [Location] |
| Employees | 136 (As of December 31, 2023) |
| Business Description | R&D, manufacture, and sales of medical devices and all related operations, as well as medical device operational management for companies within the Otsuka group |
| Shareholder | Otsuka Holdings Co., Ltd. (100%) |
Otsuka group video
To discover the Otsuka group's journey and explore its diverse business activities in
an approximately 7-minute video
Board of Directors
| President and Representative Director |
Noriko Tojo |
|---|---|
| Executive Deputy President |
Kazumichi Kobayashi |
| Executive Director | Yoshiro Matsuo |
| Executive Director | Kuniaki Natsume |
| Outside Director | Tomiko Tawaragi |
| Statutory Auditor | Yasuhiro Gomi |
| Outside Audit & Supervisory Board Member |
Naoki Miyamori |
| Executive Vice President | Shinji Iizuka |
| Senior Vice President | Christian Bell |
(As of March 8, 2024)
History
| February 2011 | Otsuka Medical Devices is newly established as holding company for Otsuka group’s medical device activities including JIMRO Co., Ltd. (apheresis business) and Otsuka Pharmaceutical’s interests in MicroPort Scientific Corporation |
|---|---|
| October 2011 | Acquisition of KiSCO Co., Ltd., a Japanese company specializing in spine and fractures |
| May 2016 | Otsuka Holdings announces collaboration with ReCor Medical, Inc. regarding an equity investment and commercialization of ReCor’s ultrasound renal denervation technology in Asia |
| February 2017 | Acquisition of Biomedical Solutions Inc., a Japanese venture designing novel stent retriever in ischemic stroke, through JIMRO Co., Ltd. |
| November 2018 | ReCor Medical, Inc. becomes fully-owned subsidiary of Otsuka Medical Devices |
| December 2018 | Veryan Medical Limited becomes fully-owned subsidiary of Otsuka Medical Devices |
| February 2022 | Transferred KiSCO’s spine and trauma businesses to Teijin Nakashima Medical Co., Ltd. |